Arrhythmia and sleep-disordered breathing in patients undergoing cardiac surgery  by Unosawa, Satoshi et al.
OA
c
S
T
H
a
b
c
a
A
R
R
A
A
K
C
V
A
I
r
h
h
b
r
a
o
c
[
i
M
T
0
dJournal of Cardiology 60 (2012) 61–65
Contents lists available at SciVerse ScienceDirect
Journal  of  Cardiology
jo u r n al hom epage: www.elsev ier .com/ locate / j j cc
riginal  article
rrhythmia  and  sleep-disordered  breathing  in  patients  undergoing
ardiac  surgery
atoshi  Unosawa  (MD,  PhD)a,∗, Akira  Sezai  (MD,  PhD)a, Toshiki  Akahoshi  (MD,  PhD)b,
etsuya  Niino  (MD,  PhD)a,  Kazuma  Shimura  (MD,  PhD)a, Motomi  Shiono  (MD,  PhD)a,
isakuni  Sekino  (MD,  PhD)c, Tsuneto  Akashiba  (MD,  PhD)b
Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan
Department of Sleep Medicine, Nihon University School of Medicine, Tokyo, Japan
Sekino Hospital, Tokyo, Japan
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 1 September 2011
eceived in revised form 13 January 2012
ccepted 25 January 2012
vailable online 7 March 2012
eywords:
ardiac surgery
entricular arrhythmia
trial ﬁbrillation
a  b  s  t  r  a  c  t
Background:  Recently,  the  role  of sleep-disordered  breathing  (SDB)  in cardiovascular  disease  has  attracted
attention. In this  study,  we  investigated  the  inﬂuence  of  SDB  on postoperative  arrhythmias  after  cardiac
surgery.
Methods  and results:  In  89 patients  undergoing  cardiac  surgery,  postoperative  portable  monitoring  for
SDB  and  Holter  electrocardiography  were  performed.  The  primary  end-points  were  the  apnea–hypopnea
index  (AHI)  and  occurrence  of  arrhythmia.  The  secondary  end-points  were:  (1)  patient  background  fac-
tors; (2)  average  heart  rate; (3) maximum  heart  rate (total,  daytime,  and  nighttime);  (4)  minimum  heart
rate (total,  daytime,  and  nighttime);  (5)  minimum  SaO2 during  sleep;  and  (6)  an  independent  predictor
for  arrhythmia.
Twenty-six patients  (29.2%)  had  an  AHI ≥  15  and  they  were  classiﬁed  into  the SDB  group,  while  patients
with  an AHI  <  15  formed  the  non-SDB  group  (70.8%).  Although  there  was  no  signiﬁcant  difference  in atrial
ﬁbrillation,  frequent  nocturnal  premature  ventricular  contractions  were  signiﬁcantly  more  common  in
the SDB  group  (19.2%)  than  the  non-SDB  group  (3.2%)  (p = 0.01).  Maximum  daytime  and  nighttime  heart
rates were  also  signiﬁcantly  higher  in  the  SDB  group.  AHI  was  a signiﬁcant  predictor  for  frequent  nocturnal
premature ventricular  contractions.
Conclusions:  This  study  showed  that  SDB  is  common  among  patients  undergoing  cardiac  surgery,  and
that  SDB  might  be  closely  associated  with  arrhythmia  in  these  patients.
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Sleep-disordered breathing (SDB) has attracted attention as a
isk factor for cardiovascular events such as hypertension, ischemic
eart disease, and cerebral infarction. It is thought that cardiac
ypertrophy, myocardial damage, and cardiac failure can be caused
y a high negative intrathoracic pressure due to obstruction of the
espiratory tract, along with hypoxemia, sympathetic overactivity,
nd the inﬂammatory response induced by SDB [1–5]. Moreover,
ccurrence of arrhythmias, such as ventricular arrhythmia, brady-
ardia, and atrial ﬁbrillation, associated with SDB has been reported
6–8]. Various arrhythmias can occur after cardiac surgery, includ-
ng atrial ﬁbrillation. Cardiac dysfunction, old age, obesity, renal
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dysfunction, and chronic obstructive pulmonary disease are con-
sidered to be factors in the occurrence of arrhythmia, and have
also been reported to inﬂuence the prognosis [9–11]. However,
few reports have been published about SDB in patients undergoing
cardiac surgery, and there have been no prospective trials.
Therefore, we  conducted portable monitoring for SDB and
Holter electrocardiography in patients undergoing cardiac surgery
to investigate the relationship between SDB and postoperative
arrhythmias.
Methods
A total of 105 patients without atrial ﬁbrillation underwent
cardiac surgery from September 2009 to March 2010 at Nihon Uni-
versity Itabashi Hospital, and the subjects consisted of 95 patients
who were transferred to Sekino Hospital for postoperative car-
diac rehabilitation. Six patients refused participation in this trial,
so 89 patients were ﬁnally examined (Fig. 1). A portable monitor
vier Ltd. All rights reserved.
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wFig. 1. Study population. A total of 89 patients were register
SAS-2100, Nihon Kohden, Tokyo, Japan) that measures the nasal
irﬂow and arterial oxygen saturation via a pulse oxymeter was
sed for diagnosis of SDB. Examinations were performed about 2
eeks after surgery. The evaluation of SDB could not be carried
ut before surgery, because this study included emergent surgery.
he presence of SDB was  deﬁned by an apnea–hypopnea index
AHI) ≥ 15. A comparative investigation was conducted by dividing
he subjects into two groups, which were an SDB group with SDB
AHI ≥ 15) and a non-SDB group with an AHI < 15. In addition, 24-h
olter electrocardiography (FM-150, Fukuda Denshi, Tokyo, Japan)
as performed during admission and the occurrence of arrhyth-
ia  was investigated. Frequent premature ventricular contractions
PVC) were deﬁned as ≥30 per hour in any 1 h. Daytime was  deﬁned
s from 6 am to 9 pm. Nighttime was deﬁned as from 9 pm to 6 am.
A prospective open, blinded end-point investigation of SDB in
atients undergoing cardiac surgery was commenced from 2009
fter approval was obtained from the Ethics Committee of Nihon
niversity Itabashi Hospital. The details of the trial were explained
o the patients and informed consent was obtained. The trial was
lso registered with the University Hospital Medical Information
etwork (UMIN) (study ID: UMIN00000 3340). The present study
as part of this trial.
ndpoints
The primary endpoints were the AHI and the occurrence of
rrhythmia. The secondary end-points were as follows: (1) patient
ackground factors; (2) average heart rate; (3) maximum heart rate
total, daytime, and nighttime); (4) minimum heart rate (total, day-
ime, and nighttime); (5) minimum SaO2 during sleep; and (6) an
ndependent predictor for arrhythmia.
tatistical analysisFor continuous variables, the mean ± standard deviation was
alculated. For comparison of two groups, a Student’s t-test was
onducted in the case of continuous variables and the 2-test
as used for categorical variables, with p < 0.05 being consideredI, apnea–hypopnea index; SDP, sleep-disordered breathing.
to indicate a signiﬁcant difference. An independent predictor for
arrhythmia was  examined using the multivariate analysis with
logistic regression from the parameters detected by univariate
analysis. SPSS11.0 software (SPSS, Chicago, IL, USA) was used for
statistical analysis.
Results
Primary endpoints
(1) AHI: Monitoring for SDB revealed an AHI > 30 in 9 patients
(10.1%) while it was from 15 to <30 in 17 patients (19.1%), 5
to <15 in 31 patients (34.8%), and <5 in 32 patients (36.0%).
There were 26 patients (29.2%) in the SDB group and 63 patients
(70.8%) in the non-SDB group (Fig. 1).
(2) Arrhythmia: Postoperative atrial ﬁbrillation was detected in 10
patients (38.5%) from the SDB group and 13 patients (20.6%)
from the non-SDB group. There was no signiﬁcant difference
(p = 0.08), but the rate was  higher in the SDB group. Fre-
quent nocturnal PVC were found in 5 patients (19.2%) from
the SDB group and 2 patients (3.2%) from the non-SDB group,
being signiﬁcantly more common in the SDB group (p = 0.01)
(Fig. 2).
Secondary endpoints
(1) Patient background factors:  The age was 64.0 ± 12.4 years in
the SDB group and 67.2 ± 12.6 years in the non-SDB group,
while there were 17 males and 9 females in the SDB group
and 40 males and 23 females in the non-SDB group, show-
ing no signiﬁcant differences. The body mass index (BMI) was
25.5 ± 3.7 kg/m2 in the SDB group and 23.6 ± 3.4 kg/m2 in the
non-SDB group, with the BMI  being signiﬁcantly higher in the
SDB group (p = 0.03). Although preoperative brain natriuretic
peptide, aortic-cross clamping time, and extracorporeal circu-
lation time were similar between the 2 groups, preoperative left
ventricular ejection fraction was  signiﬁcantly lower in the SDB
group. There were no signiﬁcant differences between the two
S. Unosawa et al. / Journal of Car
Fig. 2. Incidence of arrhythmia. Frequent premature ventricular contractions (PVC)
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Many patients who undergo cardiac surgery have lifestyle-
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et  nighttime were signiﬁcantly more common in the sleep-disordered breathing
SDB) group (p = 0.01).
groups in terms of the operative procedure and medications
(Table 1).
2) Average heart rate: The average heart rate was  80.3 ± 10.9 bpm
in the SDB group and 75.5 ± 11.7 bpm in the non-SDB group,
showing no signiﬁcant difference.
3) Maximum heart rate (total, daytime, and nighttime):  Total
maximum heart rate (SDB group: 114.0 ± 20.0 bpm, non-
SDB group: 99.8 ± 16.4 bpm, p = 0.002), the maximum daytime
heart rate (SDB group: 113.4 ± 21.2 bpm, non-SDB group:
98.6 ± 16.0 bpm, p = 0.002), and the maximum nighttime heart
able 1
atient background factors.
SDB group 
No. of patients 26 
AHI 27.5 ± 10.8 
Minimum SaO2 while sleeping (%) 78.2 ± 6.0 
Age  (years) 64.0 ± 12.4 
Gender (male:female) 17:9 
Body  mass index (kg/m2) 25.5 ± 3.7 
Diagnosis
Ischemic Heart Disease (%) 13 (50) 
Valve  (%) 8 (30.8) 
Aorta  (%) 6 (23.7) 
Others  (%) 2 (7.7) 
Hypertension (%) 18 (69.2) 
Dyslipidemia (%) 12 (46.2) 
Diabetes mellitus (%) 6 (23.1) 
Obesity (%) 3(11.5) 
Smoking (%) 10 (38.5) 
COPD  (%) 0 
Chronic kidney disease (%) 2 (7.7) 
BNP  (pg/ml) 162 ± 205 
EF  (%) 50.7 ± 14.0 
Emergent 10 (38.5) 
ACCT  (min.) 55.4 ± 36.4 
ECCT  (min.) 121 ± 42.6 
Medications
-blocker (%) 21 (80.8) 
Calcium antagonist (%) 10 (38.5) 
ARB  (%) 7 (26.9) 
ACE  inhibitor (%) 1 (3.8) 
Antiarrhythmic agent (%) 9 (34.6) 
Hypnotic (%) 3 (11.5) 
DB, sleep-disordered breathing; AHI, apnea–hypopnea index; SaO2, oxygen saturation;
jection fraction; ACCT, aortic-cross clamping time; ECCT, extracorporeal circulation timediology 60 (2012) 61–65 63
rate (group: 99.0 ± 16.6 bpm, non-SDB group: 90.8 ± 15.5 bpm,
p = 0.04) were signiﬁcantly higher in the SDB group (Table 2).
(4) Minimum heart rate (total, daytime, and nighttime):  There were
no signiﬁcant differences in the minimum heart rate between
the two groups at any time (Table 3).
(5) Minimum SaO2 during sleep: The minimum SaO2 during sleep
was 78.2 ± 6.0% in the SDB group and 87.4 ± 5.0% in the non-SDB
group, being signiﬁcantly lower in the SDB group (p < 0.001).
(6) The multivariate logistic regression analysis revealed that AHI
(odds ratio: 1.12, 95% conﬁdence limit: 1.05–1.19, p = 0.01) was
a signiﬁcant predictor for frequent nocturnal PVC (Table 4).
Discussion
In the present study, 26/89 patients (29.2%) undergoing cardiac
surgery were found to suffer from SDB. According to the Wisconsin
Sleep Cohort Study, the prevalence of sleep disorders in the gen-
eral population is 24% among men  and 9% among women for SDB
with an AHI ≥ 5, and 9.1% among men  and 4.0% among women for
SDB with an AHI ≥ 15, which was  diagnosed with polysomnography
[12]. In the present study of patients undergoing cardiac surgery,
the prevalence of SDB with an AHI ≥ 15 was 29.2%, which was  diag-
nosed with a portable monitor. A polysomnograph is a standard
device used globally to diagnose the type and severity of SDB. On
the other hand, a portable monitor is commonly used as a substitute
to diagnose SDB. Takama et al. reported that the portable monitor
was as effective as polysomnography in diagnosing SDB in patients
with cardiovascular disease. They showed that the speciﬁcity and
sensitivity of diagnosing SDB deﬁned as 20 < AHI using a portable
monitor were 86% and 81%, respectively [13].related diseases, and there have been numerous reports mention-
ing that sleeping time is closely related to the occurrence of diseases
such as obesity, diabetes, hypertension, dyslipidemia, and ischemic
Non-SDB group p-Value
63
5.95 ± 4.3 <0.0001
87.4 ± 5.0 <0.0001
67.2 ± 12.6 0.270
40:23 0.866
23.6 ± 3.4 0.03
28 (44.4) 0.633
26(41.3) 0.354
9 (14.3) 0.314
7 (11.1) 0.627
34 (54.0) 0.184
23 (36.5) 0.397
12 (19.0) 0.667
3(4.8) 0.246
15 (23.8) 0.162
5 (7.9) 0.139
3 (4.8) 0.585
128 ± 125 0.432
62.5 ± 10.4 <0.0001
19 (30.2) 0.447
54.7 ± 29.6 0.931
114 ± 32.5 0.413
44 (69.8) 0.291
18 (28.6) 0.361
16 (25.4) 0.881
2 (3.2) 0.873
22 (35.0) 0.978
19 (30.2) 0.064
 COPD, chronic obstructive pulmonary disease; BNP, brain natriuretic peptide; EF,
; ARB, angiotensin receptor blocker; ACE, angiotensin-converting enzyme.
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Table 2
Maximum heart rate.
SDB group (n = 26) Non-SDB group (n = 63) p-Value
Maximum HR (beats/min) 114.0 ± 20.0 99.8 ± 16.4 0.002
Maximum HR at nighttime (beats/min) 99.0 ± 16.6 90.8 ± 15.5 0.04
Maximum HR at daytime (beats/min) 113.4 ± 20.1 98.6 ± 16.0 0.002
SDB, sleep-disordered breathing; HR, heart rate.
Table 3
Minimum heart rate.
SDB group (n = 26) Non-SDB group (n = 63) p-Value
Minimum HR (beats/min) 62.6 ± 11.0 61.4 ± 10.0 0.639
Minimum HR at nighttime (beats/min) 64.6 ± 11.2 64.2 ± 10.4 0.890
Minimum HR at daytime (beats/min) 66.1 ± 12.7 63.8 ± 12.8 0.437
SDB, sleep-disordered breathing; HR, heart rate.
Table 4
Predictors of frequent nocturnal premature ventricular contractions.
Univariate Multivariate
fnPVC (n = 7) Non-fnPVC (n = 82) p OR 95%CI p
EF (%) 40.1 ± 11.2 60.7 ± 11.5 <0.0001
AHI 31.6 ± 18.4 10.6 ± 9.8 <0.0001 1.12 1.05–1.19 0.01
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nPVC, frequent nocturnal premature ventricular contractions; OR, odds ratio; CI, co
isease.
eart disease [14–16].  Shahar et al. reported that the odds ratios
or heart failure, stroke, and coronary heart disease in a group with
n AHI ≥ 11 were 2.38, 1.58, and 1.27, respectively [17]. Moreover,
ccording to the report by Marin et al., untreated severe obstruc-
ive sleep apnea–hypopnea signiﬁcantly increases the risk of fatal
nd non-fatal cardiovascular events compared with that in healthy
articipants [18]. In this study, most patients suffered from hyper-
ension, dyslipidemia, and diabetes mellitus. These factors were
eported to be associated with the severity of SDB [19,20]. There-
ore, we suppose that the prevalence of SDB is high because of
atients’ characteristics undergoing cardiac surgery.
Although a -blocker was given to both groups at the same
ose, the SDB group had a higher nighttime maximum heart
ate and daytime maximum heart rate, as well as more PVC at
ighttime. Kawano et al. reported that the severity of obstruc-
ive sleep apnea was independently associated with mean heart
ate during 24 h, wakefulness, and sleep [21]. The effects of SDB
n the circulatory system include psychological stress due to sleep
isorder, overload of the cardiovascular system by airway obstruc-
ion, hypoxemia, inﬂammation, and sympathetic hyperactivity.
hese factors may  induce atrial ﬁbrillation, ventricular arrhyth-
ia, and even sudden death. Guilleminault et al. studied 400
atients with SDB, among whom 48% had documented cardiac
rrhythmias, including bradyarrhythmias, sustained ventricular
achycardia, sinus arrest, second-degree atrioventricular block, and
requent PVC [22]. Moreover, in an investigation of 81 patients with
ardiac failure by Javaheri et al., central sleep apnea–hypopnea
as observed in 40% and obstructive sleep apnea–hypopnea was
bserved in 11%, and their patients with SDB had a high prevalence
f both atrial ﬁbrillation and ventricular arrhythmias [8].  Mehra
t al. studied the association between SDB with nocturnal atrial
brillation and complex ventricular ectopy in older men. Accord-
ng to the result, complex ventricular ectopy was associated most
trongly with obstructive sleep apnea, whereas atrial ﬁbrillation
as most strongly associated with central sleep apnea, suggesting
hat different sleep-related stresses may  contribute to atrial and
entricular arrhythmogenesis [23]. Bradycardia was  not detected0.028
ce interval; EF, ejection fraction; AHI, apnea–hypopnea index; IHD, ischemic heart
in the present study, but bradyarrhythmias such as sinus arrest,
sinus bradycardia, and atrioventricular block can occur in SDB [24].
It is believed that periodic nighttime apnea induces activation of
the sympathetic nervous system that persists during the daytime
as well. Another possible cause is the psychological stress that
arises as good quality sleep cannot be obtained due to recurrent
apnea.
In this study, there was no signiﬁcant difference between the
two groups in the onset of atrial ﬁbrillation following surgery, but
there was  a tendency for it to be higher in the SDB group. Atrial
ﬁbrillation is the most common rhythm complication after car-
diac surgery, and it is believed that prevention of atrial ﬁbrillation
improves the prognosis, even over the long term [10]. In a prospec-
tive study of 3543 patients, it was found that a decrease in arterial
oxygen saturation during sleep is an independent predictor of
atrial ﬁbrillation [7],  and that continuous positive airway pressure
(CPAP) treatment following deﬁbrillation signiﬁcantly prevented
the relapse of atrial ﬁbrillation [25], indicating that atrial ﬁbrillation
and SDB are related.
CPAP is an effective treatment for severe SDB. A report by He
et al. indicated that the prognosis of SDB patients with an AHI ≥ 20
is poor [26], so an AHI ≥ 20 on polysomnography has been deﬁned
as the standard for introducing CPAP in Japan. The patients who
were diagnosed as SDB in this study have undergone polysomnog-
raphy and CPAP if it was  necessary. Our study is in progress to
clarify whether CPAP can decrease arrhythmic events. It is hoped
that the aggressive screening of SDB for patients undergoing car-
diac surgery will improve the prognosis of cardiac surgery patients
with the complication of SDB.
LimitationsBecause the present study employed portable monitors to detect
SDB, there is a possibility of over-diagnosis of SDB. Further, we
could not diagnose the type of SDB (such as central or obstructive
type). Polysomnography would be necessary to achieve this.
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onclusions
Many cardiac surgery patients suffer from SDB. It is also possi-
le that SDB may  be related to the occurrence of arrhythmia after
ardiac surgery.
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